Remove Chronic pain management Remove Digital Health Remove Pain management Remove Trends
article thumbnail

Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain

Digital Health Global

As showcased in the ‘ VIRPI ‘ study, ODD-403 marks a statistically significant advancement in chronic pain management. Newel Health is well poised to leverage ODD-403’s compelling clinical findings, underscoring its commitment to delivering validated and impactful digital health solutions.

article thumbnail

Digital Musculoskeletal Investment Trends 2024 and Future Innovation in the Digital MSK market

Lloyd Price

Exec Summary: The Digital Musculoskeletal (MSK) market is attracting growing investment in 2024, driven by several key trends: 1. Investors are looking at solutions that promote self-management and preventative strategies. What is driving the Digital MSK market? Hybrid care is king: Patients are demanding flexibility.

article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Diabetes management: DTx products can assist in blood glucose control, insulin therapy management, and lifestyle modification for diabetes patients. Email lloyd@nelsonadvisors.co.uk Subscribe Today!